Commentary: Atrial Fibrillation, Statin, and Septal Myectomy

Semin Thorac Cardiovasc Surg. 2021 Autumn;33(3):720-721. doi: 10.1053/j.semtcvs.2020.12.021. Epub 2021 Feb 15.

Authors

Stephanie N Nguyen¹, Yuichi J Shimada², Shepard D Weiner², Hiroo Takayama¹

Affiliations

¹ Division of Cardiac, Thoracic and Vascular Surgery, Department of Surgery, Hypertrophic Cardiomyopathy Center, Columbia University Medical Center/NewYork-Presbyterian, New York, New York.
² Division of Cardiology, Department of Medicine, Hypertrophic Cardiomyopathy Center, Columbia University Medical Center/NewYork-Presbyterian, New York, New York.

PMID: 33600974
DOI: 10.1053/j.semtcvs.2020.12.021

No abstract available

Publication types

Editorial
Comment

MeSH terms

Atrial Fibrillation*
Coronary Artery Bypass
Heart Septum
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors